EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery

Giulia Angelini, Simona Panunzi, Maurizio Pompili, Laura Riccardi, Matteo Garcovich, Ornella Verrastro, Sara Russo iD, Tracey Mare, James Luxton, Carel W le Roux iD, Marco Raffaelli iD, Geltrude Mingrone und 1 weitere

Clinical Chemistry · 2025

DOI: 10.1093/clinchem/hvae208 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Chemistry, 2025. Verfasst von Giulia Angelini und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy. Hauptthemen laut MEDLINE: Bariatric Surgery, Fatty Liver, Liver Cirrhosis. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Noninvasive tests (NITs) to monitor metabolic dysfunction-associated steatohepatitis (MASH) progression and response to interventions are needed because of the risks of liver biopsy. A monocytes-based diagnostic test using perilipin-2 (PLIN2) and Ras-related protein-14 (RAB14) predict the severity of MASH and fibrosis. Here we compared the performances of PLIN2 and RAB14 with cytokeratin-18 (CK18) assessed by Ella™ or M65 ELISA in predicting MASH and fibrosis resolution following bariatric surgery in a longitudinal and histologically characterized cohort of individuals with obesity.

Methods

Participants in the BRAVES randomized controlled trial underwent ultrasound-guided needle liver biopsy at baseline and 1 year after surgery. We evaluated NITs’ performance using area under the receiver operating characteristic and calculated accuracy, sensitivity, and specificity based on the Youden threshold. Univariable and multivariable logistic models were used to assess the role of recorded covariates in predicting MASH and fibrosis severity, as well as resolution or improvement.

Results

After surgery, patients who experienced MASH improvement or resolution showed a significant decrease in PLIN2 expression as compared to those who did not, while patients with fibrosis improvement displayed an increase in RAB14. No differences were found for CK18. The diagnostic accuracy of PLIN2 and RAB14 for the prediction of MASH resolution or fibrosis improvement was superior to CK18 assessed by either Ella or M65 ELISA.

Conclusions

PLIN2 and RAB14, but not CK18, are markers for monitoring improvements in MASH and fibrosis after interventions such as bariatric surgery. This may reduce or eliminate the need for frequent liver biopsies. ClinicalTrials.gov Registration Number: NCT03524365

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryFatty LiverLiver CirrhosisAdultFemaleHumansMaleMiddle AgedBiomarkersEnzyme-Linked Immunosorbent AssayKeratin-18Membrane ProteinsPerilipin-2rab GTP-Binding Proteins

Substanzen

BiomarkersKeratin-18Membrane ProteinsPerilipin-2PLIN2 protein, humanrab GTP-Binding Proteins

Autor:innen und Institutionen

  • Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy.
  • CNR-IASI, Consiglio Nazionale delle Ricerche, Istituto di Analisi dei Sistemi ed Informatica, Laboratorio di Biomatematica, Rome, Italy.
  • Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Department of Clinical Biochemistry (Synnovis), King's College Hospital NHS Foundation Trust, Denmark Hill, London SE5 9RS, United Kingdom.
  • Diabetes Complication Research Centre, University College Dublin, Dublin, Ireland.
  • Department of General Surgery, Fondazione Policlinico Universitario A. Gemelli IRCSS, Rome, Italy.

ORCID-Profile: Sara Russo, Carel W le Roux, Marco Raffaelli, Royce P Vincent

Zitieren

APA

Angelini, G., Panunzi, S., Pompili, M., Riccardi, L., Garcovich, M., Verrastro, O., Russo, S., Mare, T., Luxton, J., le Roux, C. W., Raffaelli, M., Mingrone, G., & Vincent, R. P. (2025). Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae208

Vancouver

Angelini G, Panunzi S, Pompili M, Riccardi L, Garcovich M, Verrastro O, et al. Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery. Clinical Chemistry. 2025. doi:10.1093/clinchem/hvae208

BibTeX
@article{Angelini2025,
  author = {Angelini, Giulia and Panunzi, Simona and Pompili, Maurizio and Riccardi, Laura and Garcovich, Matteo and Verrastro, Ornella and Russo, Sara and Mare, Tracey and Luxton, James and le Roux, Carel W and Raffaelli, Marco and Mingrone, Geltrude and Vincent, Royce P},
  title = {Performance of Noninvasive Tests for Metabolic Dysfunction-Associated Steatohepatitis and Liver Fibrosis Resolution after Bariatric Surgery},
  journal = {Clinical Chemistry},
  year = {2025},
  doi = {10.1093/clinchem/hvae208}
}
Kostenlos starten →